Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) saw a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 840 shares, a growth of ∞ from the July 15th total of 0 shares. Based on an average daily volume of 8,927 shares, the days-to-cover ratio is currently 0.1 days.
Fortress Biotech Price Performance
NASDAQ:FBIOP opened at $18.66 on Monday. The business has a fifty day simple moving average of $19.52 and a two-hundred day simple moving average of $15.99. Fortress Biotech has a 1 year low of $6.27 and a 1 year high of $21.43.
Fortress Biotech Company Profile
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
Featured Stories
- Five stocks we like better than Fortress Biotech
- 3 Robotics Stocks Under $10: Value, Momentum, or Bet?
- 3 ETFs Built to Protect Your Money if the Bull Market Breaks
- JFrog’s AI Opportunity Could Fuel a Big Leap in Share Price
- Is SiTime the Best AI Stock You’ve Never Heard Of?
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
